ClinicalTrials.Veeva

Menu

Physical Activity and Insulin Sensitivity Dynamics

University of Copenhagen logo

University of Copenhagen

Status

Enrolling

Conditions

Insulin Sensitivity

Treatments

Procedure: Muscle Biopsy Medication: Lidocaine
Procedure: Insulin infusion
Other: One-legged-knee extensor exercise
Other: Exercise

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study investigates the role of one single bout of exercise in mediating enhancement of muscle insulin sensitivity following a single bout of exercise. Furthermore, the study is aiming to elucidate the temporal development in insulin signaling, at the early timepoints of insulin stimulation that may be responsible for the enhanced muscle insulin sensitivity.

This will be investigated in young healthy males subjected to a one-legged knee-extensor exercise followed by a hyperinsulinemic-euglycemic clamp, a setup known to enhance muscle insulin sensitivity.

Full description

The participant arrives fasting at 8:00 AM, having abstained from alcohol, nicotine, and caffeine for the past 24 hours and refrained from strenuous physical activity for the past 48 hours. The participants are then subjected to a one-legged knee extension exercise performed by the participant from 9:00 AM to 10:00 AM.

Groin catheters are inserted into the femoral artery and vein using ultrasound guidance and sterile technique

Two hours after the completion of the exercise, a catheter is inserted into an arm vein (antecubital vein) and groin catheters are inserted into the femoral artery and vein using ultrasound guidance and sterile technique. Four hours after the exercise ends, a hyperinsulinemic-euglycemic clamp is commenced. The clamp begins with a bolus injection of insulin, followed by a continuous infusion. Glucose is infused concurrently to maintain constant blood glucose levels.

Throughout the procedure, blood samples are collected every 5 minutes from the femoral catheters, and blood flow is measured using ultrasound Doppler. Muscle biopsies from the vastus lateralis of both legs are taken before the clamp starts and at 3, 6, 10, and 20 minutes after the clamp's initiation. Following the 20-minute mark, the clamp continues until steady-state is achieved to determine tissue-specific and whole-body insulin sensitivity.

Over the course of the experiment, a total of 10 muscle biopsies and approximately 150 mL of blood are collected. The experimental part of the study is expected to conclude by 4:30 PM. Participants are provided with food and beverages and observed for 1 hour before being allowed to leave the research laboratory.

Enrollment

8 estimated patients

Sex

Male

Ages

22 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy individuals (no known diseases)
  • No use of medication
  • Non-smokers
  • Male
  • Aged 22-35 years
  • Fitness level (VO2max, i.e., maximal oxygen uptake) between 30-50 mL O2/min/kg
  • BMI between 28 and 35

Exclusion criteria

  • Women
  • Failure to meet all inclusion criteria
  • Physical activity level (e.g., running, cycling, fitness, etc.) exceeding 6 hours per week
  • Acute illness within 2 weeks prior to the study days
  • Use of recreational drugs within 2 weeks prior to the study days

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

Post-exercise insulin sensitivity
Experimental group
Description:
Young healthy males will perform a single bout of knee-extensor exercise and insulin action is investigated 4 hours after cessation of exercise. Insulin action towards muscle glucose uptake will be investigated during a 120 min euglycemic hyperinsulinemic clamp.
Treatment:
Other: Exercise
Other: One-legged-knee extensor exercise
Procedure: Insulin infusion
Procedure: Muscle Biopsy Medication: Lidocaine

Trial contacts and locations

1

Loading...

Central trial contact

Jørgen FP Wojtaszewski, Professor; Nicolai S Henriksen, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems